Time-Resolved Host Transcriptomics and Network Proximity Prioritize Host-Directed Candidate Drugs for Nipah Virus Infection

Nipah virus (NiV) is a highly pathogenic zoonotic henipavirus that causes severe respiratory and neurological disease, yet no specific therapeutics are approved for human NiV infection. Because studies involving live NiV require biosafety level 4 containment and are technically demanding, computational host-directed drug repositioning provides a practical strategy for prioritizing candidates before experimental validation. Using the public NiV infection transcriptomic dataset GSE166707, we developed a time-resolved host-response drug-repositioning framework that integrated time-point differential expression analysis with time-series modeling. Core temporal genes were stratified into host dependency factors, host restriction factors and residual host-response genes using annotations from the Human–Virus Interaction DataBase. Candidate drugs were prioritized by combining Connectivity Map (CMap) reversal analysis, network proximity analysis, literature-curated NiV host-pathway directionality, pharmacological suitability and reported antiviral evidence. Suitable public drug-perturbation transcriptomic datasets were further analyzed by gene set enrichment analysis (GSEA) to evaluate their consistency with the predicted reversal directions. We identified 1116 genes differentially expressed at one or more time points and 1677 genes exhibiting significant temporal expression patterns, whose intersection defined a 516-gene core temporal host-response signature comprising 58 host dependency factors, 18 host restriction factors and 440 residual host-response genes. This signature captured a staged transition from early virus-associated recognition to inflammatory signaling, endoplasmic reticulum stress, increased protein-processing demands, and dysregulation of the cell cycle and DNA replication. Integrated screening yielded 38 candidate drugs, from which metformin, fenofibrate, lonafarnib and probenecid were prioritized as host-directed candidates warranting further experimental validation. Gene-level reversal and host-network analyses revealed drug-specific modulation of NiV-associated host programs, while external drug-perturbation GSEA supported selected host-factor reversal patterns for metformin and fenofibrate. Overall, this framework provides a reproducible strategy for prioritizing host-directed therapeutic candidates against NiV infection.

Authors

Institutions

Publication Details

Journal
Current Issues in Molecular Biology
Published
2026-11-18
DOI
https://doi.org/10.3390/cimb48111246
Primary Topic
Virology and Viral Diseases
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Time-Resolved Host Transcriptomics and Network Proximity Prioritize Host-Directed Candidate Drugs for Nipah Virus Infection

Yibo Xi, Xuechun Lu, Peng Cheng Zhao, Bin Guo et al.
2 links
Current Issues in Molecular Biology
Virology and Viral Diseases
article

Time-Resolved Host Transcriptomics and Network Proximity Prioritize Host-Directed Candidate Drugs for Nipah Virus Infection

Yibo Xi, Xuechun Lu, Peng Cheng Zhao, Bin Guo, Chuandong Hou, Xin Sun, Yujie Tang, Haojun Zhang, Wenqian Zhou, Xinwei Sun, Hongyi Li, Pengcheng Liu
article en

Abstract

Nipah virus (NiV) is a highly pathogenic zoonotic henipavirus that causes severe respiratory and neurological disease, yet no specific therapeutics are approved for human NiV infection. Because studies involving live NiV require biosafety level 4 containment and are technically demanding, computational host-directed drug repositioning provides a practical strategy for prioritizing candidates before experimental validation. Using the public NiV infection transcriptomic dataset GSE166707, we developed a time-resolved host-response drug-repositioning framework that integrated time-point differential expression analysis with time-series modeling. Core temporal genes were stratified into host dependency factors, host restriction factors and residual host-response genes using annotations from the Human–Virus Interaction DataBase. Candidate drugs were prioritized by combining Connectivity Map (CMap) reversal analysis, network proximity analysis, literature-curated NiV host-pathway directionality, pharmacological suitability and reported antiviral evidence. Suitable public drug-perturbation transcriptomic datasets were further analyzed by gene set enrichment analysis (GSEA) to evaluate their consistency with the predicted reversal directions. We identified 1116 genes differentially expressed at one or more time points and 1677 genes exhibiting significant temporal expression patterns, whose intersection defined a 516-gene core temporal host-response signature comprising 58 host dependency factors, 18 host restriction factors and 440 residual host-response genes. This signature captured a staged transition from early virus-associated recognition to inflammatory signaling, endoplasmic reticulum stress, increased protein-processing demands, and dysregulation of the cell cycle and DNA replication. Integrated screening yielded 38 candidate drugs, from which metformin, fenofibrate, lonafarnib and probenecid were prioritized as host-directed candidates warranting further experimental validation. Gene-level reversal and host-network analyses revealed drug-specific modulation of NiV-associated host programs, while external drug-perturbation GSEA supported selected host-factor reversal patterns for metformin and fenofibrate. Overall, this framework provides a reproducible strategy for prioritizing host-directed therapeutic candidates against NiV infection.

Current Issues in Molecular BiologyVol. 48(11)
Shanxi Medical University (CN), Chinese PLA General Hospital (CN)
National Natural Science Foundation of China, National Key Research and Development Program of China
Good health and well-being
Virology and Viral Diseases
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon